2OP

(2S)-2-HYDROXYPROPANOIC ACID

Created:	2004-12-29
Last modified:	2024-09-27

Find Related PDB Entry
28 entries where 2OP is found as a standalone ligand4 entries where 2OP is covalently linked to polymer or other heterogen groups 10 entries where 2OP is found in a polymer sequence

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	12
Chiral Atom Count	1
Bond Count	11
Aromatic Bond Count	0

2D diagram of 2OP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-2-HYDROXYPROPANOIC ACID
Systematic Name (OpenEye OEToolkits)	(2S)-2-hydroxypropanoic acid
Formula	C₃ H₆ O₃
Molecular Weight	90.078
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)C(O)C
SMILES	CACTVS	3.370	C[CH](O)C(O)=O
SMILES	OpenEye OEToolkits	1.7.0	CC(C(=O)O)O
Canonical SMILES	CACTVS	3.370	C[C@H](O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.0	C[C@@H](C(=O)O)O
InChI	InChI	1.03	InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1
InChIKey	InChI	1.03	JVTAAEKCZFNVCJ-REOHCLBHSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB14475
Name	L-Lactic acid
Groups	experimental approved
Synonyms	(S)-2-hydroxypropanoic acid (S)-(+)-lactic acid L-Lactic acid L-(+)-lactic acid (S)-2-hydroxypropionic acid L-(+)-α-hydroxypropionic acid (+)-lactic acid (S)-lactic acid L-Milchsäure
Brand Names	Phexxi Prismasol 2 Prismasol 4 Phexx
Categories	Hydroxy Acids Lactates
CAS number	79-33-4

Related Resource References

Resource Name	Reference
PubChem	107689
ChEMBL	CHEMBL330546
ChEBI	CHEBI:422
CCDC/CSD	YILLAG, XAMCEW, LEJMOE, PALCAH, VAKQIK, YILLAG01, YILLAG02, YILLAG03
COD	7242510, 7242509, 7242511

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.